dr mary claire haver and glp 1 GLP-1 medications were never designed to be a quick fix., In this episode of unPAUSED, Dr. Michelle Gordon explains why GLP-1s are intended to treat obesity as the chronic disease it is, not to help Dr. Mary Claire Haver is

That way, you avoid slipping back into old habits and regaining the weight you worked so hard to lose

By examining various studies, and assessed the extent to which GLP-1 can be integrated into GDM treatment protocols, considering critical parameters such as glucose control, maternal and fetal outcomes, adverse events, and overall patient acceptability

Mounjaro is designed for those with type 2 diabetes, while Zepbound targets weight management

Case Example: ePA Workflow for a GLP-1 Prescription To illustrate, consider a hypothetical case: Patient: 55-year-old female with Type 2 diabetes (HbA1c 8.7%), BMI 34, on metformin + lifestyle modifications